Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $5.67 million. The enterprise value is -$4.43 million.

Market Cap	5.67M
Enterprise Value	-4.43M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

APVO has 1.25 million shares outstanding.

Current Share Class	1.25M
Shares Outstanding	1.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+12.10%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	4.31%
Float	1.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.47
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.38.

Current Ratio	3.36
Quick Ratio	3.05
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -517.92% and return on invested capital (ROIC) is -168.51%.

Return on Equity (ROE)	-517.92%
Return on Assets (ROA)	-118.03%
Return on Invested Capital (ROIC)	-168.51%
Return on Capital Employed (ROCE)	-176.13%
Weighted Average Cost of Capital (WACC)	7.61%
Revenue Per Employee	n/a
Profits Per Employee	-$798,576
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.20% in the last 52 weeks. The beta is 1.69, so APVO's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-92.20%
50-Day Moving Average	4.89
200-Day Moving Average	13.27
Relative Strength Index (RSI)	43.41
Average Volume (20 Days)	26,249

Short Selling Information

The latest short interest is 80,160, so 6.43% of the outstanding shares have been sold short.

Short Interest	80,160
Short Previous Month	87,845
Short % of Shares Out	6.43%
Short % of Float	7.33%
Short Ratio (days to cover)	1.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.67M
Pretax Income	-26.26M
Net Income	-26.35M
EBITDA	-26.46M
EBIT	-26.67M
Earnings Per Share (EPS)	-$45.46

Full Income Statement

Balance Sheet

The company has $14.53 million in cash and $4.42 million in debt, giving a net cash position of $10.10 million or $8.11 per share.

Cash & Cash Equivalents	14.53M
Total Debt	4.42M
Net Cash	10.10M
Net Cash Per Share	$8.11
Equity (Book Value)	11.61M
Book Value Per Share	9.65
Working Capital	11.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-26.98M
Capital Expenditures	n/a
Depreciation & Amortization	214,000
Net Borrowing	n/a
Free Cash Flow	-26.98M
FCF Per Share	-$21.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-464.80%
FCF Yield	-475.89%

Analyst Forecast

The average price target for APVO is $25.50, which is 460.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.50
Price Target Difference	460.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on December 30, 2025. It was a reverse split with a ratio of 1:18.

Last Split Date	Dec 30, 2025
Split Type	Reverse
Split Ratio	1:18

Scores

Altman Z-Score	n/a
Piotroski F-Score	1